Investors Capital Advisory Services’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
$16K Hold
174
﹤0.01% 703
2016
Q1
$20K Buy
174
+4
+2% +$460 ﹤0.01% 678
2015
Q4
$28K Buy
170
+71
+72% +$11.7K 0.01% 694
2015
Q3
$20K Buy
+99
New +$20K ﹤0.01% 702